{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:46:44Z","timestamp":1761216404041},"reference-count":144,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":7633,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1023\/a:1008368500557","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:41:38Z","timestamp":1040568098000},"page":"139-150","source":"Crossref","is-referenced-by-count":32,"title":["p53-Oriented cancer therapies: Current progress"],"prefix":"10.1016","volume":"10","author":[{"given":"W.M.","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008368500557_bb0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","article-title":"p53: Puzzles and paradigm","volume":"10","author":"Ko","year":"1996","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0010","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0959-437X(97)80108-6","article-title":"p53: From inductive signal to cellular effect","volume":"7","author":"Hansen","year":"1997","journal-title":"Curr Opin Genet Dev"},{"key":"10.1023\/A:1008368500557_bb0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/379088a0","article-title":"Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours","volume":"379","author":"Graeber","year":"1996","journal-title":"Nature"},{"key":"10.1023\/A:1008368500557_bb0020","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/dna.1996.15.805","article-title":"Abrogation of p53 function affects gadd gene responses to DNA base-damaging agents and starvation","volume":"15","author":"Zhan","year":"1996","journal-title":"DNA Cell Biol"},{"key":"10.1023\/A:1008368500557_bb0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.onc.1201210","article-title":"Heat shock induces transient p53-dependent cell cycle arrest at Gl\/S","volume":"15","author":"Nitta","year":"1997","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0030","first-page":"4855","article-title":"Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis","volume":"54","author":"Greenblatt","year":"1994","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0035","first-page":"169","article-title":"TP53 tumour suppressor gene: Clues to molecular carcinogenesis and cancer therapy","volume":"28","author":"Wang","year":"1996","journal-title":"Cancer Surveys"},{"key":"10.1023\/A:1008368500557_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0959-437X(96)90004-0","article-title":"p53 In signalling checkpoint arrest or apoptosis","volume":"6","author":"Bates","year":"1996","journal-title":"Curr Opin Genet Dev"},{"key":"10.1023\/A:1008368500557_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BFb0048265","article-title":"p53: DNA damage, DNA repair and apoptosis","volume":"127","author":"Gotz","year":"1996","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1023\/A:1008368500557_bb0050","first-page":"77","article-title":"p53 in growth control and neoplasia","volume":"1287","author":"Gottlieb","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1023\/A:1008368500557_bb0055","first-page":"183","article-title":"Maintaining genetic stability through TP53 mediated checkpoint control","volume":"29","author":"Wahl","year":"1997","journal-title":"Cancer Surveys"},{"key":"10.1023\/A:1008368500557_bb0060","first-page":"6304","article-title":"Participation of p53 19; protein in the cellular response to DNA damage","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0065","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1101\/gad.8.21.2540","article-title":"DNA damage triggers a prolonged p53-dependent Gl arrest and long-term induction of Cipl in normal human fibroblasts","volume":"8","author":"Di Leonardo","year":"1994","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0070","first-page":"1169","article-title":"WAF-1\/CIP-1 is induced in p53-mediated Gl arrest and apoptosis","volume":"54","author":"El-Deiry","year":"1994","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0075","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1101\/gad.7.8.1572","article-title":"Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation","volume":"7","author":"Xiong","year":"1993","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0080","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","article-title":"p53-Dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced Gl arrest","volume":"76","author":"Dulic","year":"1994","journal-title":"Cell"},{"key":"10.1023\/A:1008368500557_bb0085","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1073\/pnas.91.12.5320","article-title":"p53-Dependent Gl arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein","volume":"91","author":"Slebos","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008368500557_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/377552a0","article-title":"Radiation-induced cell cycle arrest comprimised by p21 deficiency","volume":"377","author":"Brugarolas","year":"1995","journal-title":"Nature"},{"key":"10.1023\/A:1008368500557_bb0095","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1101\/gad.9.8.935","article-title":"p53 Dependent and independent expression of p21 during cell growth, differentiation and DNA damage","volume":"9","author":"Macleod","year":"1995","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0100","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/nar\/22.6.1012","article-title":"Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53","volume":"22","author":"Vikhanskaya","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1023\/A:1008368500557_bb0105","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1073\/pnas.92.18.8493","article-title":"p53 Controls both the G2\/M and the Gl cell cycle checkpoint and mediates growth arrest in human fibroblasts","volume":"92","author":"Agarwal","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008368500557_bb0110","first-page":"109","article-title":"Evidence for a second-cell cycle block at G2\/M by p53","volume":"10","author":"Stewart","year":"1995","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0115","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1126\/science.7871434","article-title":"A p53-dependent mouse spindle checkpoint","volume":"267","author":"Cross","year":"1995","journal-title":"Science"},{"key":"10.1023\/A:1008368500557_bb0120","first-page":"221","article-title":"Relationship of p53 to the control of apoptotic cell death","volume":"5","author":"Oren","year":"1994","journal-title":"Sem Cancer Biol"},{"key":"10.1023\/A:1008368500557_bb0125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/362849a0","article-title":"Thymocyte apoptosis induced by p53-dependent and independent pathways","volume":"362","author":"Clarke","year":"1993","journal-title":"Nature"},{"key":"10.1023\/A:1008368500557_bb0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","article-title":"p53 Is required for radiation-induced apoptosis in mouse thymocytes","volume":"362","author":"Lowe","year":"1993","journal-title":"Nature"},{"key":"10.1023\/A:1008368500557_bb0135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents","volume":"74","author":"Lowe","year":"1993","journal-title":"Cell"},{"key":"10.1023\/A:1008368500557_bb0140","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","article-title":"p53 Status and the efficacy of cancer therapy in vivo","volume":"266","author":"Lowe","year":"1994","journal-title":"Science"},{"key":"10.1023\/A:1008368500557_bb0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumour suppressor p53 is a direct transcriptional activator of the human bax gene","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"10.1023\/A:1008368500557_bb0150","first-page":"3131","article-title":"Identification of a p53-dependent negative response element in the bcl-2 gene","volume":"54","author":"Miyashita","year":"1994","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.10.1.1","article-title":"Life, death and the pursuit of apoptosis","volume":"10","author":"White","year":"1996","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0160","first-page":"199","article-title":"Molecular controls of growth arrest and apoptosis: p53-Dependent and independent pathways","volume":"11","author":"Liebermann","year":"1995","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0165","first-page":"819","article-title":"Cisplatin and paclitaxel induced apoptosis of human ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53","volume":"53","author":"Jones","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1023\/A:1008368500557_bb0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/370220a0","article-title":"p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes","volume":"370","author":"Caelles","year":"1994","journal-title":"Nature"},{"key":"10.1023\/A:1008368500557_bb0175","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1101\/gad.8.23.2817","article-title":"Myc-mediated apoptosis requires wild type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 wafl\/cipl","volume":"8","author":"Wagner","year":"1994","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0180","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1101\/gad.10.10.1219","article-title":"The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway","volume":"10","author":"Wang","year":"1996","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0185","first-page":"571","article-title":"Mutant p53 DNA clones from human colon carcinomas co-operate with ras in transforming primary rat-cells \u2013 a comparison of the hot-spot mutant phenotypes","volume":"1","author":"Hinds","year":"1990","journal-title":"Cell Growth Differential"},{"key":"10.1023\/A:1008368500557_bb0190","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0092-8674(91)90384-B","article-title":"Cotraslation of the activated mutant p53 with wild type drives the wild-type protein into the mutant conformation","volume":"65","author":"Milner","year":"1991","journal-title":"Cell"},{"key":"10.1023\/A:1008368500557_bb0195","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng0395-221","article-title":"The dominating effect of mutant p53","volume":"9","author":"Hann","year":"1995","journal-title":"Nature Genet"},{"key":"10.1023\/A:1008368500557_bb0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1346476","article-title":"Modulation of Activity of the Promoter of the Human MDR1 Gene by Ras and p53","volume":"255","author":"Chin","year":"1992","journal-title":"Science"},{"key":"10.1023\/A:1008368500557_bb0205","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1128\/JVI.66.10.6164-6170.1992","article-title":"Modulation of cellular and viral promoters by mutant human p53 protein found in tumour cells","volume":"66","author":"Deb","year":"1992","journal-title":"J Virol"},{"key":"10.1023\/A:1008368500557_bb0210","doi-asserted-by":"crossref","first-page":"6764","DOI":"10.1128\/MCB.14.10.6764","article-title":"Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle","volume":"14","author":"Chen","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1023\/A:1008368500557_bb0215","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1073\/pnas.91.13.6098","article-title":"Two cellular proteins that bind to wild-type but not mutant p53","volume":"91","author":"Iwabuchi","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008368500557_bb0220","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/362857a0","article-title":"Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53","volume":"362","author":"Oliner","year":"1993","journal-title":"Nature"},{"key":"10.1023\/A:1008368500557_bb0225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/jnci\/86.17.1265","article-title":"MDM2 and p53: A question of balance","volume":"86","author":"Meltzer","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008368500557_bb0230","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1128\/MCB.16.5.2445","article-title":"Mdm-2 inhibits the Gl arrest and apoptosis functions of the p53 tumour suppressor protein","volume":"16","author":"Chen","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1023\/A:1008368500557_bb0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0968-0004(97)01119-5","article-title":"MDM2-arbiter of p53's destruction","volume":"22","author":"Lane","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1023\/A:1008368500557_bb0240","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.92.10.4407","article-title":"Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumours","volume":"92","author":"Moll","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008368500557_bb0245","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/j.1460-2075.1992.tb05375.x","article-title":"Human papillomavirus E6 protein binds p53 in vivo and abrogates p53-mediated repression of transcription","volume":"11","author":"Lechner","year":"1992","journal-title":"EMBO J"},{"key":"10.1023\/A:1008368500557_bb0250","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1073\/pnas.91.6.2230","article-title":"Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3","volume":"91","author":"Wang","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008368500557_bb0255","first-page":"471","article-title":"HPV-18 E6 inhibits DNA binding activity regardless of the oligomeric state of p53 or the exact p53 recognition sequence","volume":"13","author":"Thomas","year":"1996","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0260","first-page":"265","article-title":"Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation","volume":"13","author":"Thomas","year":"1996","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0265","first-page":"777","article-title":"Post-translational modification of p53 and the integration of stress signals","volume":"45","author":"Meek","year":"1997","journal-title":"Pathol Biol"},{"key":"10.1023\/A:1008368500557_bb0270","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.12.18.2831","article-title":"DNA damage activates p53 through a phosphorylation-acetylation cascade","volume":"12","author":"Sakaguchi","year":"1998","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0275","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1101\/gad.11.24.3471","article-title":"DNA damage induces phosphorylation of the amino terminus of p53","volume":"11","author":"Siliciano","year":"1997","journal-title":"Genes Dev"},{"key":"10.1023\/A:1008368500557_bb0280","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1200\/JCO.1995.13.4.1009","article-title":"Implications of the p53 tumour-suppressor gene in clinical oncology","volume":"13","author":"Chang","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008368500557_bb0285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.med.47.1.285","article-title":"Clinical implications of the p53 gene","volume":"47","author":"Sidransky","year":"1996","journal-title":"Ann Rev Med"},{"key":"10.1023\/A:1008368500557_bb0290","series-title":"Important Advances in Oncology","first-page":"37","article-title":"p53 And response to chemotherapy and radiotherapy","author":"Ruley","year":"1996"},{"key":"10.1023\/A:1008368500557_bb0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001622-199511000-00013","article-title":"Cancer therpay and p53","volume":"7","author":"Lowe","year":"1995","journal-title":"Curr Opin Oncol"},{"key":"10.1023\/A:1008368500557_bb0300","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nm1095-1029","article-title":"Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvunct systemic therapy and rediotherapy","volume":"1","author":"Bergh","year":"1995","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0305","first-page":"1649","article-title":"Disruption of p53 function sensitises breast cancer MCF-7 cells to cisplatin and pentoxifylline","volume":"55","author":"Fan","year":"1995","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0310","first-page":"623","article-title":"Apoptotic death of tumour cells correlates with chemosensitivity, independent of p53 or bcl-2","volume":"2","author":"Wu","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0315","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nm0997-1034","article-title":"Cell-cycle arrest versus cell death in cancer therapy","volume":"3","author":"Waldman","year":"1997","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0320","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0092-8674(89)90045-7","article-title":"The p53 proto-oncogene can act as a suppressor of transformation","volume":"57","author":"Finlay","year":"1989","journal-title":"Cell"},{"key":"10.1023\/A:1008368500557_bb0325","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/MCB.12.3.1387","article-title":"Progression of colo-rectal-cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer","volume":"12","author":"Goyette","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1023\/A:1008368500557_bb0330","first-page":"2340","article-title":"Wild-type but not mutant p53 suppresses the growth of human lung-cancer cells bearing multiple genetic lesions","volume":"52","author":"Takahashi","year":"1992","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0335","first-page":"129","article-title":"p53 Tumour suppressor gene therapy for cancer","volume":"4","author":"Nielsen","year":"1997","journal-title":"Cancer Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jnci\/89.1.21","article-title":"Gene therapy for cancer: What have we done and where are we going","volume":"89","author":"Roth","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008368500557_bb0345","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/hum.1993.4.5-617","article-title":"Stable expression of the wild-type p53 gene in human lung-cancer cells after retrovirus-mediated gene-transfer","volume":"4","author":"Cai","year":"1993","journal-title":"Human Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0350","first-page":"4129","article-title":"A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis","volume":"53","author":"Fujiwara","year":"1993","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0355","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/jnci\/86.19.1458","article-title":"Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model","volume":"86","author":"Fujiwara","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008368500557_bb0360","first-page":"861","article-title":"Modification of tumor suppressor gene expression in non-small-cell lung cancer (nsclc) with a retroviral vector expressing wildtype (normal) p53","volume":"7","author":"Roth","year":"1996","journal-title":"Human GeneTher"},{"key":"10.1023\/A:1008368500557_bb0365","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/hum.1995.6.4-395","article-title":"Systemic gene-therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude-mice","volume":"6","author":"Lesoonwood","year":"1995","journal-title":"Human Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0370","first-page":"129","article-title":"Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts","volume":"4","author":"Nielsen","year":"1997","journal-title":"Cancer Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0375","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm0397-313","article-title":"Adenovirally transferred p6 (ink4\/cdkn2) and p53 genes cooperate to induce apoptotic tumor cell death","volume":"3","author":"Sandig","year":"1997","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0380","first-page":"251","article-title":"Bypass of abnormal mdm2 inhibition of p53-dependent growth suppression","volume":"4","author":"Meng","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0385","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/bjc.1996.431","article-title":"Selective in vitro replication of herpes simplex virus type 1 (hsv-1) icp34.5 null mutants in primary human cns tumours \u2013 evaluation of a potentially effective clinical therapy","volume":"74","author":"McKie","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008368500557_bb0390","first-page":"1137","article-title":"High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional icp27 and icp34.5","volume":"5","author":"Howard","year":"1998","journal-title":"GeneTher"},{"key":"10.1023\/A:1008368500557_bb0395","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nbt0598-440","article-title":"Intercellular delivery of functional p53 by the herpesvirus protein vp22","volume":"16","author":"Phelan","year":"1998","journal-title":"Nature Biotech"},{"key":"10.1023\/A:1008368500557_bb0400","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene-transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1023\/A:1008368500557_bb0405","first-page":"962","article-title":"In vitro and in vivo targeting of gene-expression to melanoma-cells","volume":"53","author":"Vile","year":"1993","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0410","first-page":"103","article-title":"Preliminary report: The short-term effects of direct p53 dna injection in primary hepatocellular carcinomas","volume":"20","author":"Habib","year":"1996","journal-title":"Cancer Detect Prevent"},{"key":"10.1023\/A:1008368500557_bb0415","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1357-4310(96)80004-9","article-title":"Hepatocellular carcinoma and p53 gene therapy","volume":"2","author":"Fricker","year":"1996","journal-title":"Mol Med Today"},{"key":"10.1023\/A:1008368500557_bb0420","first-page":"329","article-title":"Gene therapy for liver tumours","volume":"4","author":"Habib","year":"1997","journal-title":"Cancer Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0425","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.1994.tb21701.x","article-title":"Cationic liposomes for direct gene-transfer in therapy of cancer and other diseases","volume":"716","author":"Farhood","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"10.1023\/A:1008368500557_bb0430","first-page":"359","volume":"233","author":"Hsiao","year":"1997","journal-title":"Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival Biochem Biophys Res Communicat"},{"key":"10.1023\/A:1008368500557_bb0435","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/hum.1997.8.2-177","article-title":"Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity","volume":"8","author":"Xu","year":"1997","journal-title":"Human Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0440","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/hum.1997.8.4-467","article-title":"Transferrin-liposome-mediated p53 sensitisation of squamous cell carcinoma of the head and neck to radiation in vitro","volume":"8","author":"Xu","year":"1997","journal-title":"Human Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0445","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/jnci\/90.15.1130","article-title":"Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes","volume":"90","author":"Zou","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008368500557_bb0450","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.7521539","article-title":"Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1","volume":"265","author":"Dameron","year":"1994","journal-title":"Science"},{"key":"10.1023\/A:1008368500557_bb0455","first-page":"6161","article-title":"Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression","volume":"55","author":"Mukhopadhyay","year":"1995","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0460","first-page":"2288","article-title":"Adenovirus-mediated wild-type p53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancer","volume":"58","author":"Bouvet","year":"1998","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0465","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.onc.1201993","article-title":"p53 Induces angiogenesis-restricted dormancy in a mouse fibrosarcoma","volume":"17","author":"Holmgren","year":"1998","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0470","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.gt.3300681","article-title":"Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo","volume":"5","author":"Riccioni","year":"1998","journal-title":"Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0475","first-page":"963","article-title":"Mutant p53 potentiates protein-kinase-c induction of vascular endothelial growth-factor expression","volume":"9","author":"Kieser","year":"1994","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0480","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nm1096-1143","article-title":"Structure-based rescue of common tumor-derived p53 mutants","volume":"2","author":"Wieczorek","year":"1996","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0485","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/emboj\/17.7.1847","article-title":"Genetic selection of intragenic suppressor mutations that reverse the effects of common p53 cancer mutations","volume":"17","author":"Brachmann","year":"1998","journal-title":"EMBO J"},{"key":"10.1023\/A:1008368500557_bb0490","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0958-1669(96)80069-3","article-title":"Therapeutic targeting of the p53 tumour suppressor gene","volume":"7","author":"Beaudry","year":"1996","journal-title":"Curr Opin Biotech"},{"key":"10.1023\/A:1008368500557_bb0495","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/jnci\/88.20.1442","article-title":"Structure and function of the p53 tumor suppressor gene: Clues for rational cancer therapeutic strategies","volume":"88","author":"Harris","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008368500557_bb0500","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/j.1460-2075.1994.tb06543.x","article-title":"A temperature-sensitive mutant of human p53","volume":"13","author":"Zhang","year":"1994","journal-title":"EMBO J"},{"key":"10.1023\/A:1008368500557_bb0505","first-page":"3490","article-title":"Microinjection of monoclonal antibody PAM21 into human SW480 colorectal carcinoma cells restores the transcriptional activation function to mutant p53","volume":"55","author":"Abarzua","year":"1995","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0510","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nm0697-632","article-title":"Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 c-terminal domain","volume":"3","author":"Sehvanova","year":"1997","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0515","first-page":"933","article-title":"Geldanamycin selectively destabilizes and conformationally alters mutated p53","volume":"11","author":"Blagosklonny","year":"1995","journal-title":"Oncogene"},{"key":"10.1023\/A:1008368500557_bb0520","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/MCB.18.3.1517","article-title":"The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent","volume":"18","author":"Whitesell","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1023\/A:1008368500557_bb0525","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/excr.1997.3766","article-title":"Geldanamycin prevents nuclear translocation of mutant p53","volume":"237","author":"Dasgupta","year":"1997","journal-title":"Experiment Cell Res"},{"key":"10.1023\/A:1008368500557_bb0530","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1096\/fasebj.9.13.7557018","article-title":"Oligonucleotide-mediated modulation of mammalian gene-expression","volume":"9","author":"Scanlon","year":"1995","journal-title":"Faseb J"},{"key":"10.1023\/A:1008368500557_bb0535","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.274.5289.948","article-title":"Structure of the mdm2 oncoprotein bound to the p53 tumor suppressor transactivation domain","volume":"274","author":"Kussie","year":"1996","journal-title":"Science"},{"key":"10.1023\/A:1008368500557_bb0540","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0960-9822(06)00374-5","article-title":"Design of a synthetic mdm2-binding mini protein that activates the p53 response in vivo","volume":"7","author":"Bottger","year":"1997","journal-title":"Curr Biol"},{"key":"10.1023\/A:1008368500557_bb0545","first-page":"158","article-title":"Engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants","volume":"56","author":"Waterman","year":"1996","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0550","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI1140","article-title":"CtsI: A p53-derived chimeric tumor suppressor gene with enhanced in vitro apoptotic properties","volume":"101","author":"Conseiller","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1023\/A:1008368500557_bb0560","first-page":"5","article-title":"P73 \u03b2, unlike p53, suppresses growth and induces apoptosis of human papillomavirus e6-expressing cancer cells","volume":"13","author":"Prabhu","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1023\/A:1008368500557_bb0565","first-page":"4285","article-title":"Characterization of the p53 tumor suppressor pathway in cell lines of the national cancer institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents","volume":"57","author":"Oconnor","year":"1997","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0570","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nm0796-724","article-title":"p53 Activity and chemotherapy","volume":"2","author":"Delia","year":"1996","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0575","first-page":"1536","article-title":"Cispaltin, camptothecin and Taxol sensitivities of cells with p53-associated multidrug resistance","volume":"50","author":"Vasey","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1023\/A:1008368500557_bb0580","first-page":"870","article-title":"p53 Status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel","volume":"57","author":"Debernardis","year":"1997","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0585","first-page":"1047","article-title":"Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after Taxol or vincristine treatment","volume":"4","author":"Fan","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0590","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm0196-72","article-title":"Loss of normal p53 function confers sensitization to Taxol by increasing G2\/M arrest and apoptosis","volume":"2","author":"Wahl","year":"1996","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0595","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/oxfordjournals.annonc.a058614","article-title":"p53: A target for new anticancer drugs or a target for old drugs","volume":"4","author":"Brown","year":"1993","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008368500557_bb0600","first-page":"199","article-title":"Suppression of lung-cancer cell-growth by ribozyme-mediated modification of p53 pre-messenger-rna","volume":"2","author":"Cai","year":"1995","journal-title":"Cancer Gene Ther"},{"key":"10.1023\/A:1008368500557_bb0605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10428199409059593","article-title":"Selective cytotoxicity to human leukemic myeloblasts produced by oligodeoxyribonucleotide phosphorothioates complementary to p53 nucleotide-sequences","volume":"12","author":"Bayever","year":"1994","journal-title":"Leuk Lymph"},{"key":"10.1023\/A:1008368500557_bb0610","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/gyno.1995.1272","article-title":"Combination anti-gene therapy targeting c-myc and p53 in ovarian-cancer cell-lines","volume":"59","author":"Janicek","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1008368500557_bb0615","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1200\/JCO.1996.14.4.1320","article-title":"Phase I trial of an antisense oligonucleotide ol(l)p53 in hematologic malignancies","volume":"14","author":"Bishop","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008368500557_bb0620","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/gyno.1996.0014","article-title":"p53 Gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines","volume":"60","author":"Skilling","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1008368500557_bb0625","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/scd.1.1997.6.441","article-title":"Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide ol(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome","volume":"6","author":"Bishop","year":"1997","journal-title":"J Hematother"},{"key":"10.1023\/A:1008368500557_bb0630","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/bjc.1995.88","article-title":"Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression","volume":"71","author":"Barton","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008368500557_bb0635","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","article-title":"p53 In hematologic malignancies","volume":"84","author":"Imamura","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008368500557_bb0640","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0167-5699(96)30019-4","article-title":"The humoral response to the tumor-suppressor gene-product p53 in human cancer: Implications for diagnosis and therapy","volume":"17","author":"Soussi","year":"1996","journal-title":"Immunol Today"},{"key":"10.1023\/A:1008368500557_bb0645","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1357-4310(97)01003-4","article-title":"p53 As a target for anti-cancer immunotherapy","volume":"3","author":"Chen HL,Carbone","year":"1997","journal-title":"Mol Med Today"},{"key":"10.1023\/A:1008368500557_bb0650","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/hyb.1995.14.139","article-title":"Mutant oncopeptide immunization induces ctl specifically lysing tumor-cells endo-genously expressing the corresponding intact mutant p53","volume":"14","author":"Ciernik","year":"1995","journal-title":"Hybridoma"},{"key":"10.1023\/A:1008368500557_bb0655","first-page":"1175","article-title":"Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the hla a-asterisk-0201 peptide consensus motif","volume":"54","author":"Wiedenfeld","year":"1994","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008368500557_bb0660","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1084\/jem.183.4.1357","article-title":"Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines","volume":"183","author":"Mayordomo","year":"1996","journal-title":"J Exp Med"},{"key":"10.1023\/A:1008368500557_bb0665","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.186.5.695","article-title":"Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes","volume":"186","author":"Vierboom","year":"1997","journal-title":"J Exp Med"},{"key":"10.1023\/A:1008368500557_bb0670","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/eji.1830270332","article-title":"Cytotoxic T lymphocyte responses to wild-type and mutant mouse p53 peptides","volume":"27","author":"Bertholet","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1023\/A:1008368500557_bb0675","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1073\/pnas.93.10.4781","article-title":"p53 As a target for cancer vaccines: Recombinant canarypox virus vectors expressing p53 protects mice against lethal tumour cell damage","volume":"93","author":"Roth","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008368500557_bb0680","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nm0698-710","article-title":"Idiotypic immunization induces immunity to mutated p53 and tumor rejection","volume":"4","author":"Ruiz","year":"1998","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0685","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1073\/pnas.93.9.4192","article-title":"Converting cancer genes into killer genes","volume":"93","author":"DaCosta","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1023\/A:1008368500557_bb0690","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumour cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"10.1023\/A:1008368500557_bb0695","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"Onyx-015, an E1B gene attenuated adenovirus, causes tumour-specific cytolysis and antitumoural efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Heise","year":"1997","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0700","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/357082a0","article-title":"Inhibition of p53 transactivation required for transformation by adenovirus early lb-protein","volume":"357","author":"Yew","year":"1992","journal-title":"Nature"},{"key":"10.1023\/A:1008368500557_bb0705","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1006\/viro.1997.8782","article-title":"p53\/Elb58kDa complex regulates adenovirus replication","volume":"237","author":"Ridgway","year":"1997","journal-title":"Virology"},{"key":"10.1023\/A:1008368500557_bb0710","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.71.1.548-561.1997","article-title":"The early region IB 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle","volume":"71","author":"Goodrum","year":"1997","journal-title":"J Virol"},{"key":"10.1023\/A:1008368500557_bb0715","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/2057","article-title":"p53-Dependent cell death\/apoptosis is required for a productive adenovirus infection","volume":"4","author":"Hall","year":"1998","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0720","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/2000","article-title":"Killing tumour cells with viruses-a question of specificity","volume":"4","author":"Lane","year":"1998","journal-title":"Nature Med"},{"key":"10.1023\/A:1008368500557_bb0725","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/hum.1998.9.9-1323","article-title":"A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy","volume":"9","author":"Freytag","year":"1998","journal-title":"Human Gene Ther"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419570739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419570739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/10\/2\/139\/19477155\/10-2-139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:43:44Z","timestamp":1682009024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419570739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":144,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["S0923753419570739"],"URL":"https:\/\/doi.org\/10.1023\/a:1008368500557","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}